GHK‑copper is a three‑amino‑acid peptide that tightly complexes with copper ions. Dr. Jason Schuster explains that this small molecule can re‑activate dormant cellular pathways that are critical for hair follicle health and overall tissue regeneration.
A tiny peptide with big potential
GHK (glycine‑histidine‑lysine) is a naturally occurring tripeptide that has a high affinity for copper. In the video Dr. Schuster notes that copper itself is antibacterial and antiviral, and when paired with GHK it becomes a powerful regulator of many biological processes, from skin health to bone remodeling.
How GHK‑copper drives hair growth
According to Dr. Schuster, GHK‑copper boosts the expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), both of which promote new blood‑vessel formation essential for follicle nourishment. It also modulates gene expression—turning down over‑active oncogenic genes and enhancing collagen synthesis, inflammation reduction, and mitochondrial ATP production.
- Binds copper → stabilizes Cu⁺⁺ in tissues
- Up‑regulates bFGF and VEGF for angiogenesis
- Down‑regulates 70% of over‑expressed genes in metastatic colon‑cancer models
- Stimulates collagen pathways and macro‑phage migration
- Improves mitochondrial function and reduces oxidative stress
Why it matters for hair and beyond
Dr. Schuster highlights that the primary consumer use is for reversing hair loss, but the peptide also supports wound healing, bone repair, skin rejuvenation, and may aid in cancer‑related gene modulation. Its broad tissue‑remodeling activity makes it a versatile addition to anti‑aging protocols.
- Promotes hair‑follicle regrowth
- Accelerates wound and skin healing
- Enhances bone‑cell attachment and healing
- Reduces inflammation and oxidative damage
- Improves overall cellular health and longevity
Practical guidance
The video cites Dr. Edwin Lee’s recommended dosing protocols. Topical delivery (spray or dropper) is typically 5 mg per day, with visible results after about three months. Injectable use is 2.5 mg subcutaneously three times per week. GHK‑copper has an excellent safety profile; the only reported toxic dose comes from a mouse study (LD₅₀ ≈ 8 mg for a 25 g mouse, extrapolated to ~320 mg/kg for humans).
- Topical: 5 mg daily (spray or dropper)
- Injectable: 2.5 mg SC three times/week
- Observe results after ~3 months of consistent use
- No serious adverse events reported in human studies
- Lethal dose in mice far exceeds therapeutic range
“By taking GHK, you're turning down the expression of the genes that are producing the proteins that lead to certain cancers.”— Dr. Jason Schuster
Dr. Schuster's short takes on this topic — tap to play.
Go deeper than the summary
Dr. Schuster's accredited courses on supplementation, epigenetics, and peptide therapy — the full research, dosing, and video breakdowns.